Stada Arzneimittel AG – Strategy, SWOT and Corporate Finance Report

Stada Arzneimittel AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company

Key Highlights

Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers portfolio of products in various therapeutic categories including pain, women's health, cardiovascular conditions and diabetes. Few of its major generic products include including Tilidin Naloxon, Atorvastatin, Epoetin zeta and Diclofenac. Its major branded products include APO-Go, Grippostad, Snup, Fultium and Vitaprost. The company operates across Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. STADA is headquartered in Bad Vilbel, Germany.

Scope

Detailed information on Stada Arzneimittel AG required for business and competitor intelligence needs

A study of the major internal and external factors affecting Stada Arzneimittel AG in the form of a SWOT analysis

An in-depth view of the business model of Stada Arzneimittel AG including a breakdown and examination of key business segments

News about Stada Arzneimittel AG, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Stada Arzneimittel AG and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Stada Arzneimittel AG as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Stada Arzneimittel AGs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Vifor Pharma Ltd

Turing Pharmaceuticals AG

MorphoSys AG

MediGene AG

HC Berlin Pharma AG

Evotec AG

EGIS Pharmaceuticals Plc

Biotest AG

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Stada Arzneimittel AG - Key Facts

Stada Arzneimittel AG - Key Employees

Stada Arzneimittel AG - Key Employee Biographies

Stada Arzneimittel AG - Major Products and Services

Stada Arzneimittel AG - History

Stada Arzneimittel AG - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Stada Arzneimittel AG - Business Description

Product Category: Branded Products

Overview

Performance

Product Category: Generics

Overview

Performance

Geographical Segment: Germany

Performance

Geographical Segment: Italy

Performance

Geographical Segment: Other Countries

Performance

Geographical Segment: Russia

Performance

Geographical Segment: Serbia

Performance

Geographical Segment: United Kingdom

Performance

R&D Overview

Stada Arzneimittel AG - Corporate Strategy

Stada Arzneimittel AG - SWOT Analysis

SWOT Analysis - Overview

Stada Arzneimittel AG - Strengths

Stada Arzneimittel AG - Weaknesses

Stada Arzneimittel AG - Opportunities

Stada Arzneimittel AG - Threats

Stada Arzneimittel AG - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Stada Arzneimittel AG, Recent Deals Summary

Section 5 Company’s Recent Developments

May 15, 2019: STADA Health Report 2019: Half of Europeans are ready for Dr Robot and treatments via webcam

Mar 19, 2019: STADA to hire hundreds of employees - Strong increase in earnings

Mar 19, 2019: STADA with strong growth momentum in 2018

Oct 11, 2018: STADA wins 2018 Global Generics & Biosimilars Award in Company of the Year, EMEA category

Sep 12, 2018: STADA invites the holders of the STADA Bond to participate in the bondholders meeting and to vote in favor of the proposed resolutions

Sep 03, 2018: Peter Goldschmidt to succeed Claudio Albrecht as STADA's CEO

Aug 09, 2018: STADA's business development in the first six months of 2018 as expected

May 03, 2018: STADA with solid business development in the first quarter of 2018

Apr 16, 2018: Changes in the management team of STADA

Mar 08, 2018: STADA records positive business development in 2017

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Stada Arzneimittel AG, Key Facts

Stada Arzneimittel AG, Key Employees

Stada Arzneimittel AG, Key Employee Biographies

Stada Arzneimittel AG, Major Products and Services

Stada Arzneimittel AG, History

Stada Arzneimittel AG, Subsidiaries

Stada Arzneimittel AG, Key Competitors

Stada Arzneimittel AG, Ratios based on current share price

Stada Arzneimittel AG, Annual Ratios

Stada Arzneimittel AG, Annual Ratios (Cont…1)

Stada Arzneimittel AG, Annual Ratios (Cont…2)

Stada Arzneimittel AG, Interim Ratios

Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Stada Arzneimittel AG, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Stada Arzneimittel AG, Performance Chart (2013 – 2017)

Stada Arzneimittel AG, Ratio Charts

Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports